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Abstract Poliovirus protease 2A pr° has been efficiently ex- 
pressed in HeLa and COS cells upon transfection with vector 
pTM1-2A and infection with the recombinant vaccinia virus bear- 
ing the I"7 RNA polymerase. The expressed pofiovirus protease 
localizes to the cytoplasm of the transfected cells, both in the 
endoplasmic retieulum and in vesicles cattered in the cytoplasm. 
Cleavage of p220, a component of initiation factor eIF-4F, selec- 
tively occurs from 5 h post-infection in transfected cells infected 
with the recombinant virus. This cleavage correlates in time with 
the profound inhibition observed in the synthesis of vaccinia virus 
proteins. A similar blockade of vesicular stomatitis virus transla- 
tion takes place upon 2A pr° expression. Finally, the synthesis of 
poliovirus protein 2C from a recombinant vaccinia virus that 
expresses this protein under the EMC untranslated leader region 
is not affected by the synthesis of 2A pr°. These findings lend 
support to the idea that translation of capped mRNAs requires 
the integrity of p220, while this requirement is not observed when 
translation of a mRNA bearing a picornavirus leader region is 
assayed. 
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1. Introduction 
Translation of picornavirus RNA originates a large polypro- 
tein precursor that is proteolytically cleaved by the virus en- 
coded proteases to the mature viral products [1-3]. Apart from 
a final cleavage of VP0 to generate VP2 and VP0 during virion 
assembly, 2A pr° and 3C pr° are the two poliovirus proteases 
responsible for all the cleavages on the polyprotein [1,3]. Polio- 
virus 2A pr° and 3C pr° not only cleave viral precursor substrates, 
cellular proteins are also recognized and degraded by these 
proteases [3,4]. Thus, the p220 component of initiation factor 
eIF-4F is cleaved internally once by 2A or° probably inactivating 
this factor to recognize capped mRNAs [5,6]. On this basis, the 
possibility that p220 cleavage constitutes the basis of the inhibi- 
tion of cellular translation was advanced [5]. However, subse- 
quent evidence indicated that p220 cleavage and the shut-off of 
host protein synthesis by poliovirus may be unrelated phenom- 
ena [7 10]. Therefore, great interest exists to express the iso- 
lated 2A p~° in mammalian cells to assay directly its effects on 
translation. Early attempts aimed to test the effects of 2A pr° 
transient expression on reporter genes indicated that 2A pr° was 
deleterious to gene expression 115;3725}, being the transcrip- 
tion of the reporter gene more affected, than its translation [11]. 
*Corresponding author. Fax: (34) (1) 3974799. 
Attempts to make recombinant vaccinia virus bearing 2A pr° 
were unsuccessful, because of the toxicity of this protein for the 
replication of vaccinia virus [12,13]. We have now efficiently 
expressed poliovirus 2A pr° in a transient manner by means of 
recombinant vaccinia virus that contains the T7 RNA poly- 
merase. The effects of 2A pr° expression on translation in vaccinia 
virus and vesicular stomatitis virus-infected cells was assayed. 
Our results indicate that expression of 2A or° and subsequent 
cleavage of p220 leads to substantial inhibition of translation 
in both systems. 
2. Materials and methods 
2.1. Cells and virus 
HeLa and COS cells were grown in tissue-culture dishes (Nunc) in 
Dulbecco's modified Eagle's medium (DMEM) supplemented with 5% 
Newborn calf serum. The recombinant vaccinia virus bearing the T7 
RNA polymerase (VT7) (kindly given by Dr. B. Moss, NIH, Bethesda, 
MD) and the vesicular stomatitis virus (VSV) were grown in HeLa cells 
in DMEM supplemented with 2% Newborn calf serum. 
2.2. Plasmid constructions 
The expression plasmid pTM 1-2A was constructed using standard 
polymerase chain reaction (PCR) techniques. Oligonucleotides were 
designed to hybridize with the regions 3386-3403 (primer 5' 2A.B 1/El: 
CCC GGG GAT ATC ATG GGATTCGGACACCAAAAC) and 
3832-3815 (primer 3' 2A.E1A: GGG CCC GAG CTC AGG CCT TAC 
TA TTGTTCCATGGCTTCTTC) of poliovirus type 1 cDNA cloned 
in vector pT7XLD. Amplified products were purified using the Gene- 
Clean kit. The DNA preparation amplified was doubly digested with 
EcoRV + SacI and ligated to pTM1 vector [14] digested with SacI and 
blunt ended NcoI. Recombinant vaccinia virus VTM2C was prepared 
essentially as described [15,16]. 
2.3. Transfection of DNAs with the VT7 expression system 
For transfection experiments, cells were plated in 24-well dishes 
(Nunc) 24 h before infection with VT7 (m.o.i. 5). After 45 min of virus 
adsorption, a mixture of DNA (0.5/,tg/well) and Lipofectin (2 pg/well) 
was added to cells in DMEM as described by the manufacturer 
(GIBCO, BRL). Cells were harvested at the times indicated in figure 
legends. 
2.4. Protein analysis by SDS-PAGE. Immunoblot assays 
Cells were labelled with 25 pCi/ml [35S]methionine (1.45 Ci/mmol, 
Amersham) in methionine-free medium. The radiolabelled cell mono- 
layers were dissolved in buffer and electrophoresed as indicated [16]. 
Samples used for immunoblot analysis of p220 were harvested in sam- 
ple buffer with 1 mM PMSF at the indicated times. After boiling, the 
samples were applied and electrophoresed as indicated in SDS-PAGE 
gels in each figure legend. Proteins were transferred to a nitrocellulose 
membrane (trans-blot transfer medium, Bio-Rad) overnight at 200 mA 
in a transfer buffer (25 mM Tris-HC1, (pH 8.3), 90 mM glycine, 20% 
methanol). Prelabelled molecular weight markers (Bio-Rad) were used 
to allow cutting the nitrocellulose heet at the desire position. Thus, the 
nitrocellulose with the proteins above 16 kDa were incubated with 
rabbit polyclonal antibodies against p220 [17], and proteins below 16 
kDa were incubated with rabbit polyclonal antibodies against 2A pr° 
[18]. The membrane was developed by the luminol-luciferin system and 
exposed to X-Ray film for 10 s to 15 min depending on the signal. 
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2.5. Immunomicroscopy 
For immunofluorescence microscopy HeLa cells were washed three 
times with PBS and fixed with 20% methanol 2 min. After fixation the 
ceils were washed with PBS. After rinsing the cells three times, primary 
antibody binding was visualized with goat anti-rabbit FITC or goat 
anti-mouse RITC diluted in PBS for 1 h (the polyclonal primary anti- 
body was added first). After three washes in PBS the cover slips were 
mounted on glass slides in mowiol and viewed with a Nikon Fluophot 
microscope. Staining of the endoplasmic reticulum was carried out with 
anti-PDI (Protein disulphide isomerase) antibodies (1D3, kindly given 
by Dr. D. Fiiller, EMBL, Heidelberg). 
3. Results 
Initially, the poliovirus 2A pr° was cloned in vector pTM1 as 
described for other poliovirus proteins [16]. The expression of 
this protein in HeLa cells was tested by immunofluorescence. 
To this end, cells transfected ornot with pTM 1-2A and infected 
with recombinant vaccinia virus bearing the T7 RNA poly- 
merase (VT7) were incubated with specific polyclonal antibodies 
against poliovirus 2A pr°. Control cells only infected with VT7 
do not show immunofluorescence when reacted with this anti- 
body, while timmuno fluorescence is clearly apparent in cells 
infected and transfected with pTM1-2A (Fig. 1). More than 
70% of the cells show 2A pr° expression using this assay, albeit 
to various extents. A small percentage (about 10%) of the cells 
express the protease to high levels. The intracellular distribu- 
tion of the protein shows its localization in the endoplasmic 
reticulum and some additional vesicles located in the cyto- 
plasm. Specific staining of the endoplasmic reticulum in these 
cells was achieved by means of anti-PDI antibodies (1D3) (Fig. 
l). PDI is a marker of the endoplasmic reticulum [19]. 
The activity of poliovirus 2A pr° on p220 cleavage and vac- 
cinia virus translation was examined at the times shown in Fig, 2. 
Infection of COS cells with recombinant vaccinia virus alone 
does not affect the integrity of p220 (Fig. 2; panel A), whereas 
infection plus transfection with pTM1-2A leads to substantial 
cleavage of p220 after 5 h p.i. and more drastically after 24 h 
of infection. Profound inhibition of vaccinia virus protein syn- 
thesis is observed from 5 h p.i. in cells transfected with pTM 1-2A 
(Fig. 2C). The extent of this inhibition and the fact that 
there is little p220 left intact indicate that the percentage of 
transfected cells is very high. Therefore, this system is well 
suited to test the action of poliovirus 2A pr° on translation, 
overcoming the construction of recombinant vaccinia virus 
bearing 2A pr°. The actual synthesis of poliovirus 2A pr° was 
examined by Western blotting using polyclonal antibodies 
against his protease. Some expression of 2A pr° is detected 7 h 
p.i., while at 24 h p.i. the intensity of the band corresponding 
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Fig. 1. Intracellular localization of poliovirus 2A pr° protein. HeLa cells were infected with VT7 (left panels) or transfected with pTM 1-2A (right panels) 
and 8 h post-transfection immunoreacted with anti-2A antiserum (upper panels) or anti-PDI (1D3) antiserum (lower panels). 
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Fig. 2. Kinetics of p220 cleavage, 2A pr°, expression and protein synthesis n COS cells. Cells were infected with VT7 (5 pfu/cell) and transfected with 
pTM1-2A plasmid. Samples were obtained at the indicated times for immunoblot analysis as described in section 2. Panel A: the blot was incubated 
with p220 antibodies. Panel B: the blot was incubated with 2A antibody. Panel C: proteins were labelled with [35S]methionine at the indicated times 
for 1 h and analyzed by 15% SDS-PAGE. P, poliovirus-infeeted COS cells; PD, products of p220 degradation; Ac, actin. 
to 2A pr° is similar to the amount of 2A pr° present in poliovirus- 
infected cells (Fig. 2B). Despite the low amounts of 2A pr° ob- 
served at 5 and 7 h p.i. its effects on p220 cleavage are clearly 
apparent (Fig. 2A). 
Many of the initial effects of poliovirus on the translation of 
capped mRNAs, assayed VSV mRNAs as a model for cap- 
dependent translation [20,21]. Therefore, we decided to assay 
the action of poliovirus 2A pr° on the translation of VSV 
mRNAs. For this purpose, COS cells infected with recombi- 
nant vaccinia virus were superinfected with VSV previously 
transfected or not with pTM1-2A. When vaccinia virus-in- 
fected COS cells are superinfected with VSV, the proteins en- 
coded by VSV are clearly apparent, although their level of 
expression is reduced as compared to cells infected with VSV 
alone (Fig. 3A). Notably, the synthesis of VSV proteins is very 
much reduced in COS cells previously transfected with polio- 
virus 2A pr° (Fig. 3A). These findings indicate that 2A pr° is not 
only deleterious for vaccinia virus translation, but also the 
synthesis of VSV proteins is greatly compromised by the ex- 
pression of the poliovirus protease. 
Finally, the action of poliovirus 2A pr° on gene expression by 
a recombinant vaccinia virus that synthesizes poliovirus protein 
2C under the control of the EMC 5'UTR was assayed. Polio- 
virus 2C is one of the major proteins ynthesized by this recom- 
binant vaccinia virus at late times of infection (Fig. 3B). Gene 
expression i doubly infected cells with VT7 and vTM2C trans- 
fected with pTM1-2A is profoundly depressed, in agreement 
with the idea that protease 2A pr° blocks vaccinia virus transla- 
tion. Notably, the synthesis of protein 2C by the recombinant 
vaccinia virus is not affected by 2A pr°. These findings indicate 
that the translation of a mRNA incorporating the EMC 5'UTR 
is much less affected by poliovirus 2A pr° than the translation 
of the rest of vaccinia virus mRNAs. These in vivo observations 
lend support o the idea that internal initiation of this picor- 
navirus UTR does not require an intact p220. 
4. Discussion 
The finding that 2A pr° cleaves p220 provides an useful tool 
to assay the requirement of this polypeptide in translation [22]. 
Two major approaches have been followed. The first one in- 
volves the addition of picornavirus proteases to cell lysates in 
order to deplete for p220. Upon cleavage of p220, the transla- 
tion of capped or uncapped mRNAs is assayed [23]. The other 
approach involves the expression of 2A pr° in intact cells to assay 
for its effects on gene expression [11,24]. Addition of several 
picornavirus 2A pr° to cell-free systems results in efficient cleav- 
age of p220 [25-27]. However, the effects of this cleavage on the 
translation of capped mRNAs is still conflicting [28,29]. Initial 
studies found substantial (but not total) inhibition of globin 
mRNA translation [30], but more recent experiments show only 
marginal, about 30% in some instances [29], or none inhibition 
[28]. Interestingly, translation of naturally or even artificially 
uncapped mRNAs is sometimes stimulated by the presence of 
the picornavirus protease in the cell-free system [28,29]. Curi- 
ously, no studies with poliovirus 2A pr° have yet been performed 
using cell free lysates. It remains till unclear if the enhanced 
translation by picornavirus protease on uncapped mRNAs is 
due to the actual presence of the protease, or to the cleavage 
of p220 and consequent enhanced activity of the cleaved prod- 
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Fig. 3. Panel A: effects of 2A pr° expression on protein synthesis in cells co-infected with VSV and VT7 expressing 2A pr°. COS cells grown in 24-well 
dishes were infected with VT7 (m.o.i. 5), and after virus adsorption transfected with pTM1-2A. At 7 h.p. transfection ceils were superinfected with 
VSV (m.o.i. 50). Proteins were labelled with [35S]methionine at 10 h p.t. for 1 h. Panel B: effects of 2A pr° expression on poliovirus 2C synthesis from 
recombinant vaccinia virus. COS cells coinfected with VT7 (m.o.i. 5) and VTM2C (m.o.i. 5) were transfected with pTM1-2A and 24 h p.i. proteins 
were labelled for 1 h at the indicated time. All the samples were analyzed by 15% SDS-PAGE. 
ucts. The stimulation of translation of uncapped mRNAs was 
initially observed in whole cells using the poliovirus 2A pr° [31]. 
Therefore, it seems possible that poliovirus 2A pr° is a multifunc- 
tional enzyme. This protease cleaves p220 and blocks gene 
expression of reporter genes [11,24] and potently inhibits the 
synthesis of some viral protein (the present work). In addition 
2A pr° stimulates translation of its own mRNAs [31], resembling 
in this respect he activity of other viral proteins as HIV rev 
[32,33], influenza NS1 [34]. 
The role that 2A pr° plays in the shut-off of host translation 
induced by poliovirus is still much debated [7-10]. The possibil- 
ity that apart from p220 cleavage, there is a second event re- 
sponsible for this effect has been speculated [35,36]. However, 
the present work shows that the individual expression of polio- 
virus 2A pr° restricts the translation of both vaccinia virus and 
VSV protein synthesis, leaving unnecessary the existence of a 
second event. Our present results together with previous find- 
ings on the inhibition of reporter genes by 2A pr° clearly point 
to the toxic effects of this protease for gene expression. Note- 
worthy, in all these studies translation of newly made mRNAs 
was tested, while the poliovirus-induced inhibition of cellular 
translation occurs on the translation of mRNAs already en- 
gaged in translation. Previous findings from several aborato- 
ries indicate that p220 cleavage can be separated from the 
inhibition of protein synthesis in poliovirus-infected HeLa cells 
[7 10]. The possibility that 2A pr° blocks expression of newly 
made mRNAs, having less or no effect on ongoing translation 
is open. Experiments are now in progress in our laboratory to 
test this possibility. 
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